HSKA Stock - Heska Corporation
Unlock GoAI Insights for HSKA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $257.31M | $253.74M | $197.32M | $122.66M | $127.45M |
| Gross Profit | $111.17M | $105.79M | $81.29M | $54.45M | $56.64M |
| Gross Margin | 43.2% | 41.7% | 41.2% | 44.4% | 44.4% |
| Operating Income | $-20,298,000 | $-993,000 | $-8,192,000 | $-4,589,000 | $3.75M |
| Net Income | $-18,424,000 | $132,000 | $-14,032,000 | $-1,137,000 | $5.85M |
| Net Margin | -7.2% | 0.1% | -7.1% | -0.9% | 4.6% |
| EPS | $-1.78 | $0.01 | $-1.62 | $-0.15 | $0.74 |
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| January 6th 2023 | Morgan Stanley | Downgrade | Underweight | $58 |
Earnings History & Surprises
HSKAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | May 3, 2024 | — | — | — | — |
Q1 2024 | Feb 26, 2024 | — | — | — | — |
Q4 2023 | Nov 6, 2023 | — | — | — | — |
Q3 2023 | Aug 14, 2023 | $0.40 | — | — | — |
Q2 2023 | May 5, 2023 | $0.32 | $0.17 | -46.9% | ✗ MISS |
Q1 2023 | Feb 28, 2023 | $0.38 | $0.55 | +44.7% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $0.45 | $0.41 | -8.9% | ✗ MISS |
Q3 2022 | Aug 8, 2022 | $0.37 | $0.34 | -8.1% | ✗ MISS |
Q2 2022 | May 9, 2022 | $0.41 | $0.27 | -34.1% | ✗ MISS |
Q1 2022 | Feb 28, 2022 | $0.32 | $0.35 | +9.4% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $0.31 | $0.20 | -35.5% | ✗ MISS |
Q3 2021 | Aug 3, 2021 | $-0.19 | $0.50 | +363.2% | ✓ BEAT |
Q2 2021 | May 6, 2021 | $0.09 | $0.59 | +555.6% | ✓ BEAT |
Q1 2021 | Feb 23, 2021 | $-0.10 | $0.72 | +820.0% | ✓ BEAT |
Q4 2020 | Nov 5, 2020 | $-0.12 | $0.08 | +166.7% | ✓ BEAT |
Q3 2020 | Aug 4, 2020 | $-0.25 | $-0.72 | -189.7% | ✗ MISS |
Q2 2020 | May 7, 2020 | $-0.25 | $-0.14 | +44.0% | ✓ BEAT |
Q1 2020 | Feb 25, 2020 | $-0.01 | $0.07 | +649.9% | ✓ BEAT |
Q4 2019 | Nov 5, 2019 | $-0.02 | $-0.03 | -55.6% | ✗ MISS |
Q3 2019 | Aug 6, 2019 | $-0.07 | $-0.03 | +57.1% | ✓ BEAT |
Latest News
Frequently Asked Questions about HSKA
What is HSKA's current stock price?
What is the analyst price target for HSKA?
What sector is Heska Corporation in?
What is HSKA's market cap?
Does HSKA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to HSKA for comparison